This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
Human defensins are effective against SARS-CoV-2 and may enhance vaccine responses.
Why it matters
Understanding the role of defensins could lead to improved antiviral treatments and more effective vaccines, especially in the context of emerging viruses like SARS-CoV-2.
How the study worked
The study is a review of existing literature on human defensins and their roles in immunity and vaccine enhancement.
What this study cannot tell us
The study is primarily a literature review and does not include new experimental data.
Read the original research
Human Defensins from Antivirals to Vaccine Adjuvants: Rediscovery of the Innate Immunity Arsenal.
Protein and peptide letters, 29(2), 121-124
Citation
Zupin, Luisa; Crovella, Sergio. (2022). Human Defensins from Antivirals to Vaccine Adjuvants: Rediscovery of the Innate Immunity Arsenal.. Protein and peptide letters, 29(2), 121-124. https://doi.org/10.2174/0929866528666211125110058